INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

20,958 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
7
EW
Eddy Robert W.Director, President & CEO
BJBJ's Wholesale Club Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$517K
5,000 sh
Oct 15, 2026Oct 15, 2026
Page 71 of 524
← PrevNext →
traded Oct 15, 2026
+0d
SEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$171K
640 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$126K
476 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$54K
200 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$220K
883 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$156K
600 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$21K
27 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$39K
50 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$11K
14 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$26K
35 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$42K
55 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$9,242
12 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$19K
25 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$4,523
6 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$18K
24 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$30K
38 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$12K
16 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

4
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$397K
2,500 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

4
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$662K
4,200 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

4
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$290K
1,800 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

4
KR
Kumaraswami RaviPres. Worldwide Field Ops.
RSKDRISKIFIED LTD.
Open-market sale · 10b5-1 plan
SELL$543K
65.0K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

4
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$275K
1,700 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

4
BS
Boughton SoleilChief Legal Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$101K
3,461 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

4
EW
Eddy Robert W.Director, President & CEO
BJBJ's Wholesale Club Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$209K
2,000 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

4
EW
Eddy Robert W.Director, President & CEO
BJBJ's Wholesale Club Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$105K
1,000 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

4
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$529K
3,408 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

3
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
160 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

1
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$192K
1,200 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

1
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$82K
500 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

1
Robinhood Markets, Inc.10% Owner
RVIRobinhood Ventures Fund I
Open-market sale · 10b5-1 plan
SELL$110K
4,362 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

1
Robinhood Markets, Inc.10% Owner
RVIRobinhood Ventures Fund I
Open-market sale · 10b5-1 plan
SELL$114K
4,537 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

1
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$114K
700 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

1
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
1,452 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

1
Huffman Steve LaddDirector, CEO & President, 10% Owner
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$203K
1,300 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

47
WH
Woersching Eric H.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$205K
1,000 sh
Oct 9, 2026Oct 14, 2026
traded Oct 9, 2026
+5dSEC Form 4

Evidence

36
Suzan K. DelBeneDJoint
TDTriborough Bridge & 4% SPL Tax Due 11/15/31
Sale
SELL$250K – $500KSep 18, 2026Oct 14, 2026
traded Sep 18, 2026
+26dHouse PTR

Evidence

34
RS
Ray SumitaChief Legal Compliance Officer, Corporate Secretary
CUECue Biopharma, Inc.
Open-market sale
SELL$52K
1,844 sh
Oct 12, 2026Oct 14, 2026
traded Oct 12, 2026
+2dSEC Form 4

Evidence

33
MM
Murphy Kevin MichaelDirector, See Remarks
FERGFerguson Enterprises Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$2.44M
11.3K sh
Oct 12, 2026Oct 14, 2026
traded Oct 12, 2026
+2dSEC Form 4

Evidence

33
BW
Brundage WilliamDirector, Chief Financial Officer
FERGFerguson Enterprises Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$1.31M
5,986 sh
Oct 12, 2026Oct 14, 2026
traded Oct 12, 2026
+2dSEC Form 4

Evidence

33
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$275K
10.0K sh
Oct 12, 2026Oct 14, 2026
traded Oct 12, 2026
+2dSEC Form 4

Evidence